 MONTREAL, Sept. 19, 2022 GLOBE NEWSWIRE -- Theratechnologies Inc. Theratechnologies or the Company TSX: TH NASDAQ: THTX, a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that Paul Levesque, President and Chief Executive Officer, will participate on the Novel Targets in Oncology: Risk vs. Reward panel, at the Cantor Oncology, Hematology HemeOnc Conference to be held at the New York Palace Hotel, on Wednesday, September 28, 2022, at 9:00 a.m. ET, in New York City. The presentation is available only to attendees of the conference: 